SMALL CELL LUNG CARCINOMA (SCLC)
Clinical trials for SMALL CELL LUNG CARCINOMA (SCLC) explained in plain language.
Never miss a new study
Get alerted when new SMALL CELL LUNG CARCINOMA (SCLC) trials appear
Sign up with your email to follow new studies for SMALL CELL LUNG CARCINOMA (SCLC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough lung cancer: drug combo trial launches
Disease control OngoingThis study tests a new drug, BI 764532, combined with chemotherapy in adults with advanced small cell lung cancer that returned after prior treatment. The goal is to find the safest dose and see if the combination can help control the cancer. Participants continue treatment as lo…
Matched conditions: SMALL CELL LUNG CARCINOMA (SCLC)
Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated May 26, 2026 11:23 UTC
-
New drug combo aims to boost immune system against tough lung cancers
Disease control OngoingThis early-phase trial tests a new drug combination (obrixtamig plus ezabenlimab) in adults with advanced small cell lung cancer or other neuroendocrine tumors that have not responded to standard treatments. The goal is to find the highest safe dose and see if the drugs can help …
Matched conditions: SMALL CELL LUNG CARCINOMA (SCLC)
Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated May 26, 2026 11:22 UTC
-
New hope for aggressive lung cancer: experimental drug joins standard care
Disease control OngoingThis early-stage trial tests a new experimental drug called BI 764532 (obrixtamig) combined with standard chemotherapy and immunotherapy for adults with extensive-stage small cell lung cancer. The main goal is to find the highest safe dose of the new drug. Participants receive al…
Matched conditions: SMALL CELL LUNG CARCINOMA (SCLC)
Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated May 22, 2026 13:51 UTC